Using Caenorhabditis elegans as a model organism for evaluating extracellular signal-regulated kinase docking domain inhibitors

Journal of Cell Communication and Signaling

Volumn 2, Issue 3-4, 2008, Pages 81-92

  Chen, Fengming ^a   MacKerell Jr , Alexander D ^a   Luo, Yuan ^a   Shapiro, Paul ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Docking domain inhibitors; Extracellular signal regulated kinase; Model organism; Signal transduction

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RAS PROTEIN;

ARTICLE; CAENORHABDITIS ELEGANS; CELL FUSION; CELL MATURATION; CONTROLLED STUDY; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; STEM CELL;

CAENORHABDITIS ELEGANS;

EID: 61549112487     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-008-0034-2     Document Type: Article

References (60)

1. Abramczyk O, Rainey MA, Barnes R, Martin L, Dalby KN (2007) Expanding the repertoire of an ERK2 recruitment site: Cysteine footprinting identifies the D-recruitment site as a mediator of Ets-1 binding. Biochemistry 46(32):9174-9186 doi: 10.1021/bi7002058
2. Aronov AM, Baker C, Bemis GW, Cao J, Chen G, Ford PJ, Germann UA, Green J, Hale MR, Jacobs M, Janetka JW, Maltais F, Martinez-Botella G, Namchuk MN, Straub J, Tang Q, Xie X (2007) Flipped out: Structure-guided design of selective pyrazolylpyrrole ERK inhibitors. J Med Chem 50(6):1280-1287 doi: 10.1021/jm061381f
3. Artal-Sanz M, de Jong L, Tavernarakis N (2006) Caenorhabditis elegans: A versatile platform for drug discovery. Biotechnol J 1(12):1405-1418 doi: 10.1002/biot.200600176
4. Beitel GJ, Clark SG, Horvitz HR (1990) Caenorhabditis elegans ras gene let-60 acts as a switch in the pathway of vulval induction. Nature 348(6301):503-509 doi: 10.1038/348503a0
5. Bollag G, Freeman S, Lyons JF, Post LE (2003) Raf pathway inhibitors in oncology. Curr Opin Investig Drugs 4(12):1436-1441
6. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77(1):71-94
7. Byerly L, Cassada RC, Russell RL (1976) The life cycle of the nematode Caenorhabditis elegans. I. Wild-type growth and reproduction. Dev Biol 51(1):23-33 doi: 10.1016/0012-1606(76)90119-6
8. Canagarajah BJ, Khokhlatchev A, Cobb MH, Goldsmith EJ (1997) Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90(5):859-869 doi: 10.1016/S0092-8674(00)80351-7
9. Chen F, Hancock CN, Macias AT, Joh J, Still K, Zhong S, MacKerell AD Jr, Shapiro P (2006) Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure. Bioorg Med Chem Lett 16(24):6281-6287 doi: 10.1016/j.bmcl.2006.09.038
10. Cohen P (1999) The development and therapeutic potential of protein kinase inhibitors. Curr Opin Chem Biol 3(4):459-465 doi: 10.1016/ S1367-5931(99)80067-2
11. Dempsey CM, Mackenzie SM, Gargus A, Blanco G, Sze JY (2005) Serotonin (5HT), fluoxetine, imipramine and dopamine target distinct 5HT receptor signaling to modulate Caenorhabditis elegans egg-laying behavior. Genetics 169(3):1425-1436 doi: 10.1534/genetics.104.032540
12. Dengg M, van Meel JC (2004) Caenorhabditis elegans as model system for rapid toxicity assessment of pharmaceutical compounds. J Pharmacol Toxicol Methods 50(3):209-214 doi: 10.1016/j.vascn.2004.04.002
13. Dimitri CA, Dowdle W, MacKeigan JP, Blenis J, Murphy LO (2005) Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo. Curr Biol 15(14):1319-1324 doi: 10.1016/j.cub.2005.06.037
14. English JM, Cobb MH (2002) Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23(1):40-45 doi: 10.1016/S0165-6147(00)01865-4
15. Epstein HF, Shakes DC (1995) Methods in cell biology, Caenorhabditis elegans: Modern biological analysis of an organism, vol. 48. Academic, New York
16. Fantz DA, Jacobs D, Glossip D, Kornfeld K (2001) Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues. J Biol Chem 276(29):27256-27265 doi: 10.1074/jbc.M102512200
17. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, Shaw PE (1995) ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 14(5):951-962
18. Gupta BP, Wang M, Sternberg PW (2003) The C. elegans LIM homeobox gene lin-11 specifies multiple cell fates during vulval development. Development 130(12):2589-2601 doi: 10.1242/dev.00500
19. Hancock CN, Macias A, Lee EK, Yu SY, Mackerell AD Jr, Shapiro P (2005) Identification of novel extracellular signal-regulated kinase docking domain inhibitors. J Med Chem 48(14):4586-4595 doi: 10.1021/jm0501174
20. Hobert O, D'Alberti T, Liu Y, Ruvkun G (1998) Control of neural development and function in a thermoregulatory network by the LIM homeobox gene lin-11. J Neurosci 18(6):2084-2096
21. Hurd DD, Kemphues KJ (2003) PAR-1 is required for morphogenesis of the Caenorhabditis elegans vulva. Dev Biol 253(1):54-65 doi: 10.1006/ dbio.2002.0866
22. Inoue T, Sherwood DR, Aspock G, Butler JA, Gupta BP, Kirouac M, Wang M, Lee PY, Kramer JM, Hope I, Burglin TR, Sternberg PW (2002) Gene expression markers for Caenorhabditis elegans vulval cells. Gene Expr Patterns 2(3-4):235-241 doi: 10.1016/S1567-133X(02)00055-8
23. Jacobs D, Beitel GJ, Clark SG, Horvitz HR, Kornfeld K (1998) Gain-of-function mutations in the Caenorhabditis elegans lin-1 ETS gene identify a C-terminal regulatory domain phosphorylated by ERK MAP kinase. Genetics 149(4):1809-1822
24. Jacobs D, Glossip D, Xing H, Muslin AJ, Kornfeld K (1999) Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev 13(2):163-175 doi: 10.1101/ gad.13.2.163
25. Janknecht R, Ernst WH, Pingoud V, Nordheim A (1993) Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J 12(13):5097-5104
26. Kohno M, Pouyssegur J (2003) Pharmacological inhibitors of the ERK signaling pathway: Application as anticancer drugs. Prog Cell Cycle Res 5:219-224
27. Kohno M, Pouyssegur J (2006) Targeting the ERK signaling pathway in cancer therapy. Ann Med 38(3):200-211 doi: 10.1080/07853890600551037
28. Lackner MR, Kim SK (1998) Genetic analysis of the Caenorhabditis elegans MAP kinase gene mpk-1. Genetics 150(1):103-117
29. Lackner MR, Kornfeld K, Miller LM, Horvitz HR, Kim SK (1994) A MAP kinase homolog, mpk-1, is involved in ras-mediated induction of vulval cell fates in Caenorhabditis elegans. Genes Dev 8(2):160-173 doi: 10.1101/gad.8.2.160
30. Lee MH, Ohmachi M, Arur S, Nayak S, Francis R, Church D, Lambie E, Schedl T (2007) Multiple functions and dynamic activation of MPK-1 extracellular signal-regulated kinase signaling in Caenorhabditis elegans germline development. Genetics 177(4):2039-2062 doi: 10.1534/ genetics.107.081356
31. Lewis TS, Shapiro PS, Ahn NG (1998) Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49-139 doi: 10.1016/ S0065-230X(08)60765-4
32. Macias AT, Mia MY, Xia G, Hayashi J, MacKerell AD Jr (2005) Lead validation and SAR development via chemical similarity searching; application to compounds targeting the pY+3 site of the SH2 domain of p56lck. J Chem Inf Model 45(6):1759-1766 doi: 10.1021/ci050225z
33. Martin MC, Allan LA, Mancini EJ, Clarke PR (2008) The docking interaction of caspase-9 with ERK2 provides a mechanism for the selective inhibitory phosphorylation of caspase-9 at threonine 125. J Biol Chem 283(7):3854-3865 doi: 10.1074/jbc.M705647200
34. Michaux G, Legouis R, Labouesse M (2001) Epithelial biology: Lessons from Caenorhabditis elegans. Gene 277(1-2):83-100 doi: 10.1016/ S0378-1119(01)00700-4
35. Miley GR, Fantz D, Glossip D, Lu X, Saito RM, Palmer RE, Inoue T, Van Den Heuvel S, Sternberg PW, Kornfeld K (2004) Identification of residues of the Caenorhabditis elegans LIN-1 ETS domain that are necessary for DNA binding and regulation of vulval cell fates. Genetics 167(4):1697-1709 doi: 10.1534/genetics.104.029017
36. Mohler WA, Shemer G, del Campo JJ, Valansi C, Opoku-Serebuoh E, Scranton V, Assaf N, White JG, Podbilewicz B (2002) The type I membrane protein EFF-1 is essential for developmental cell fusion. Dev Cell 2(3):355-362 doi: 10.1016/S1534-5807(02)00129-6
37. Ohori M, Kinoshita T, Okubo M, Sato K, Yamazaki A, Arakawa H, Nishimura S, Inamura N, Nakajima H, Neya M, Miyake H, Fujii T (2005) Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex. Biochem Biophys Res Commun 336(1):357-363 doi: 10.1016/j.bbrc.2005.08.082
38. Page AP, Johnstone IL (2007) The cuticle. WormBook 19:1-15
39. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22(2):153-183 doi: 10.1210/er.22.2.153
40. Reiner D, González-Pérez V, Der C, Cox A (2008) Use of Caenorhabditis elegans to evaluate inhibitors of Ras function in vivo. Methods Enzymol 439:425-449 doi: 10.1016/S0076-6879(07)00430-2
41. Reuter CW, Morgan MA, Bergmann L (2000) Targeting the Ras signaling pathway: A rational, mechanism-based treatment for hematologic malignancies? Blood 96(5):1655-1669
42. Robinson FL, Whitehurst AW, Raman M, Cobb MH (2002) Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1. J Biol Chem 277(17):14844-14852 doi: 10.1074/jbc.M107776200
43. Sebolt-Leopold JS (2004) MEK inhibitors: A therapeutic approach to targeting the Ras-MAP kinase pathway in tumors. Curr Pharm Des 10(16):1907-1914 doi: 10.2174/1381612043384439
44. Shapiro P (2002) Ras-MAP kinase signaling pathways and control of cell proliferation: Relevance to cancer therapy. Crit Rev Clin Lab Sci 39(4-5):285-330 doi: 10.1080/10408360290795538
45. Sheridan DL, Kong Y, Parker SA, Dalby KN, Turk BE (2008) Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs. J Biol Chem 283(28):19511-19520 doi: 10.1074/ jbc.M801074200
46. Stiernagle T (2006) Maintenance of C. elegans. WormBook 11:1-11
47. Strayer A, Wu Z, Christen Y, Link CD, Luo Y (2003) Expression of the small heat-shock protein Hsp16-2 in Caenorhabditis elegans is suppressed by Ginkgo biloba extract EGb 761. FASEB J 17(15):2305-2307
48. Sulston J, Hodgkin J (1988) Methods. In: Wood WB (ed) "The nematode Caenorhabditis elegans". Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 587-606
49. Tan PB, Lackner MR, Kim SK (1998) MAP kinase signaling specificity mediated by the LIN-1 Ets/LIN-31 WH transcription factor complex during C. elegans vulval induction. Cell 93(4):569-580 doi: 10.1016/ S0092-8674(00)81186-1
50. Tanoue T, Adachi M, Moriguchi T, Nishida E (2000) A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol 2(2):110-116 doi: 10.1038/35000065
51. Tanoue T, Maeda R, Adachi M, Nishida E (2001) Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J 20(3):466-479 doi: 10.1093/emboj/20.3.466
52. Thompson N, Lyons J (2005) Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery. Curr Opin Pharmacol 5(4):350-356 doi: 10.1016/j.coph.2005.04.007
53. Tiensuu T, Larsen MK, Vernersson E, Tuck S (2005) lin-1 has both positive and negative functions in specifying multiple cell fates induced by Ras/MAP kinase signaling in C. elegans. Dev Biol 286(1):338-351 doi: 10.1016/j.ydbio.2005.08.007
54. Trent C, Tsuing N, Horvitz HR (1983) Egg-laying defective mutants of the nematode Caenorhabditis elegans. Genetics 104(4):619-647
55. Wagmaister JA, Gleason JE, Eisenmann DM (2006) Transcriptional upregulation of the C. elegans Hox gene lin-39 during vulval cell fate specification. Mech Dev 123(2):135-150 doi: 10.1016/j.mod.2005.11.003
56. Wallace EM, Lyssikatos JP, Yeh T, Winkler JD, Koch K (2005) Progress towards therapeutic small molecule MEK inhibitors for use in cancer therapy. Curr Top Med Chem 5(2):215-229 doi: 10.2174/1568026053507723
57. Wilson MA, Shukitt-Hale B, Kalt W, Ingram DK, Joseph JA, Wolkow CA (2006) Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans. Aging Cell 5(1):59-68 doi: 10.1111/ j.1474-9726.2006.00192.x
58. Wu Y, Han M (1994) Suppression of activated Let-60 ras protein defines a role of Caenorhabditis elegans Sur-1 MAP kinase in vulval differentiation. Genes Dev 8(2):147-159 doi: 10.1101/gad.8.2.147
59. Zhang F, Strand A, Robbins D, Cobb MH, Goldsmith EJ (1994) Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Nature 367(6465):704-711 doi: 10.1038/367704a0
60. Zhang J, Zhou B, Zheng CF, Zhang ZY (2003) A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates. J Biol Chem 278(32):29901-29912 doi: 10.1074/jbc.M303909200